SCHEMBL2196197

SCHEMBL2196197

Cc1ccc(NC(=O)CCS(C)(=O)=O)cc1C(=O)c1ccc(Nc2ccc(F)cc2F)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 10/20 0.53
MAPK13 O15264 9/20 0.53
MAPK12 P53778 9/20 0.53
MAPK11 Q15759 9/20 0.53
KMT2A Q03164 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
AVPR2 P30518 1/20 0.42
OXTR P30559 1/20 0.42
AVPR1A P37288 1/20 0.42
MAPT P10636 2/20 0.42
IDH1 O75874 1/20 0.41
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
EGFR P00533 1/20 0.38
ERBB2 P04626 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199162 0.89 MAPK13 (0.57) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL2200097 0.87 MAPK13 (0.59) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL2198811 0.86 MAPK13 (0.54) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL2198486 0.86 MAPK13 (0.54) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL2571430 0.84 KMT2A (0.44) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL2197746 0.83 MAPK13 (0.54) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL2569783 0.82 MAPK14 (0.58) MAPK14MAPK13MAPK12MAPK11AVPR2
SCHEMBL2574702 0.82 MAPK13 (0.49) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL2199640 0.82 MAPK13 (0.52) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL2200533 0.81 MAPK14 (0.61) MAPK14MAPK13MAPK12MAPK11CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US claimed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP claimed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed
EP-1658263-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS Leo Pharma A/S (DK) 2006-05-24 EP disclosed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK14 697/4885MAPK13 1063/4885MAPK12 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.